Publication | Closed Access

VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor

Antiproliferative EffectGliomaG Protein-coupled ReceptorMedicineReceptor (Biochemistry)Neuropeptide ReceptorVip2 ReceptorPharmacologyCell BiologyCell SignalingTumor MicroenvironmentPituitary Adenylate CyclaseNeuropeptides